论文部分内容阅读
目的观察可元胶囊治疗单纯型糖尿病性视网膜病变(DR)的临床疗效和安全性。方法以自身前后对照方法观察50例单纯型DR患者服用羟苯磺酸钙1、2、3个月后的视力和荧光眼底血管造影的变化,以及应用生化检查分析患者血液流变学的变化。结果单纯型DR患者服用药物后全血黏度(H及L)、红细胞压积均有明显下降,视功能改善的有效率为88%。治疗期间患者未出现明显不适及药物不良反应。结论可元胶囊治疗单纯型糖尿病性视网膜病变安全有效。
Objective To observe the clinical efficacy and safety of Keyuan capsule in the treatment of simple diabetic retinopathy (DR). Methods The changes of visual acuity and fluorescence fundus angiography in 50 simple DR patients taking calcium dobesilate 1, 2, and 3 months after operation were observed by self-control method. The hemorrheology was analyzed by biochemical tests. Results After treatment with DR, the whole blood viscosity (H and L), hematocrit decreased significantly, and the effective rate of improving visual function was 88%. Patients during treatment did not appear obvious discomfort and adverse drug reactions. Conclusion Ke yuan capsule for the treatment of simple diabetic retinopathy is safe and effective.